期刊文献+

兔动脉粥样硬化模型中NO和PAI-1的表达及阿托伐他汀的干预作用 被引量:8

Expressions of nitric oxide and plasminogen activator inhibitor type-1 in rabbit models of atherosclerosis and interference effect of atorvastatin
下载PDF
导出
摘要 目的:探讨兔动脉粥样硬化模型中一氧化氮(NO)和血浆纤溶酶原激活物抑制物-1(PAI-1)的表达及阿托伐他汀的干预作用。方法:24只雄性日本大耳白兔随机分为高脂饮食组(A组)、高脂饮食+阿托伐他汀组(B组)和正常饮食组(C组),每组8只。各组分别在喂养16周末处死,ELISA法检测NO和PAI-1。全自动生化分析仪检测血清脂蛋白的表达水平。结果:NO的表达水平B组显著高于A组和C组(P<0.01),A组与C组比较差异无显著性(P>0.05)。PAI-1的表达水平B组低于A组和C组(P<0.01),A组与C组比较差异无显著性(P>0.05)。A、B、C三组总胆固醇(TC)水平分别为(23.51±10.58)、(14.27±3.51)和(1.36±0.33)mmol·L-1,三组间两两比较差异有显著性(P<0.05)。A、B、C三组低密度脂蛋白(LDL)水平分别为(21.39±10.00)、(14.23±4.01)和(0.72±0.35)mmol·L-1,三组间两两比较差异有显著性(P<0.05)。甘油三酯(TG)水平三组间比较差异无显著性(P>0.05)。结论:高脂饮食对兔动脉粥样硬化模型中NO和PAI-1表达水平无明显影响,阿托伐他汀干预使NO表达水平升高,使PAI-1表达水平降低,有利于抑制动脉粥样硬化的进程。 Objective To investigate the expressions of nitric oxide (NO) and plasminogen activator inhibitor type-1 (PAI-1) in rabbit models of atherosclerosis and the interference effect of atorvastatin. Methods Twenty four male Japanese rabbits were divided into 3 groups (8 in each group): high-fat diet group (group A), high-fat plus atorvastatin group (group B) and normal diet group (group C). The expressions of NO and PAI-1 were detected with ELISA assay. Plasma lipid was detected with automatic analysis divice. Results The espression of NO in group B was significantly higher than those in groups A and group C (P〈0.01); there was no significant difference between groups A and C (P〉0.05). The expression of PAI-1 in group B was significantly lower than those in groups A and C, there was no significant difference between groups A and group C (P〉0.05). The levels of serum TC in groups A, B, and C were (23.51±10.58), (14.27±3.51) and (1.36±0.33) mmol·L^-1, respectively; the levels of serum LDL in groups A, B, and C were (21.39±10.00), (14.23±4.01) and (0.72±0.35) mmol·L^-1; there were significant differences between three groups (P〈0.05), while TG had no significant difference between three groups (P〉0.05). Conclusion High-fat diet has no significant effect on the expressions of NO and PAI-1 in atherosclerosis rabbits . Atorvastatin can increase the expression of NO and decrease the expression of PAI-1, and can inhibit the progression of atherosclerosis.
出处 《吉林大学学报(医学版)》 CAS CSCD 北大核心 2007年第4期671-674,777,共5页 Journal of Jilin University:Medicine Edition
基金 吉林省科技厅基金资助课题(200505173)
关键词 动脉粥样硬化 一氧化氮 血浆纤溶酶原激活物抑制物-1 阿托伐他汀 atherosclerosis nitric oxide plasminogen activator inhibitor type-l atorvastatin
  • 相关文献

参考文献7

  • 1Anderson TJ,Gerhard MD,Meredith IT,et al.Systemic nature of endothelial dysfunction in atherosclerosis.[J].Am J Cardiol,1995,75 (6):71B-74B.
  • 2Lupu F,Bergonzelli GE,Heim DA,et al.Localization and production of plasminogen activator inhibitor-1 in human healthy and atherosclerotic arteries[J].Arterioscler Thromb,1993,13 (7):1090-1100.
  • 3张玉玲,周淑娴,雷娟,王景峰.冠状动脉粥样硬化性心脏病危险因素与血管紧张素转换酶基因多态性及纤溶酶原激活物抑制物1活性的相关性[J].中国组织工程研究与临床康复,2007,11(4):657-660. 被引量:5
  • 4Feron O,Dessy C,Moniotte S,et al.Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase[J].J Clin Invest,1999,103 (6):897-905.
  • 5Carmeliet P,Kieckens L,Schoonjans L,et al.Plasminogen activator inhibitor-1 gene deficient mice in generation by homologou srecombination and characterization[J].J Clin Invest,1993,92 (6):2746-2755.
  • 6Tzoulaki I.Murray GD.Price JF.et al.Hemostatic factors,inflammatory markers,and progressive peripheral atherosclerosis:the Edinburgh Artery Study[J].Am J Epidemiol,2006,163 (4):334-341.
  • 7McKenney JM.Potential nontraditional applications of statins[J].Ann Pharmacother,2003,37 (7-8):1063-1071.

二级参考文献21

共引文献4

同被引文献127

引证文献8

二级引证文献74

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部